|Bid||102.35 x 900|
|Ask||102.41 x 800|
|Day's range||102.11 - 104.34|
|52-week range||61.19 - 105.30|
|Beta (5Y monthly)||0.67|
|PE ratio (TTM)||20.08|
|Earnings date||28 Oct 2021|
|Forward dividend & yield||1.72 (1.66%)|
|Ex-dividend date||01 Sept 2021|
|1y target est||92.14|
Houlihan Lokey (HLI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Synchrony Financial's (SYF) third-quarter results benefit on the back of improved purchase volume and reduced expenses.
Zacks.com featured highlights include: Regeneron Pharm, Evercore, Houlihan Lokey and DICK'S Sporting Goods